Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

BaRupOn Healthcare integrates pharmacy, distribution, and biomedical innovation to strengthen U.S. healthcare supply ...